Ignite Creation Date:
2025-12-24 @ 5:07 PM
Ignite Modification Date:
2025-12-29 @ 8:43 PM
Study NCT ID:
NCT01632150
Status:
COMPLETED
Last Update Posted:
2017-04-14
First Post:
2012-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-05
Start Date Type:
None
Primary Completion Date:
2013-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03
Completion Date Type:
ACTUAL
First Submit Date:
2012-06-28
First Submit QC Date:
None
Study First Post Date:
2012-07-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-12-22
Results First Submit QC Date:
None
Results First Post Date:
2016-02-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-12-03
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-03-17
Last Update Post Date:
2017-04-14
Last Update Post Date Type:
ACTUAL